Boston Scientific (BSX) stock drops to 52-week low of $59.32, down 37% YTD. Analysts cut targets after guidance reduction and Penumbra deal concerns.
Original Image Link
Source:blockonomi.com
Original Image Link
Source:blockonomi.com
Posted: 2026-04-28 08:05:00

















